文献速递头颈外科

头颈癌幸存者中焦虑和抑郁障碍的治疗与死亡率降低相关

Reduced Mortality With Treatment of Anxiety and Depression Among Head and Neck Cancer Survivors.
PubMed 文献 · Laryngoscope · 2025-06-11

这项回顾性队列研究利用TriNetX去标识化电子病历数据,纳入258,259例成人头颈癌幸存者,其中65,486例(25.4%)诊断有焦虑和/或抑郁障碍。倾向性评分匹配后,焦虑和/或抑郁障碍(HR 1.07,95%CI 1.05-1.09)及焦虑障碍(HR 1.08,95%CI 1.05-1.10)与死亡率风险升高相关,抑郁障碍则无显著关联(HR 1.01,95%CI 0.99-1.04);在接受药物治疗和/或心理治疗的患者中,死亡风险较未治疗者降低。

要点

  • 头颈癌幸存者中焦虑和/或抑郁障碍患病率为25.4%(65,486/258,259)。
  • 焦虑和/或抑郁障碍与死亡风险升高相关(HR 1.07,95%CI 1.05-1.09)。
  • 接受药物和/或心理治疗者死亡风险降低(HR 0.94,95%CI 0.91-0.97)。

核心结论

  • 该回顾性队列研究提示,焦虑和/或抑郁障碍病史与头颈癌幸存者较差的生存相关,而治疗该焦虑和/或抑郁障碍可能减轻这种增加的死亡风险。

研究设计与样本

  • 回顾性队列研究,使用TriNetX去标识化电子病历数据。
  • 研究对象为成人头颈癌幸存者,共258,259例。
  • 生成有和无特定焦虑和/或抑郁障碍诊断的队列;在诊断焦虑和/或抑郁障碍者中,再分为接受和未接受治疗两组。
  • 采用Kaplan-Meier曲线比较倾向性评分匹配相关人口学和医学特征后的组间死亡风险。

主要发现

  • 258,259例成人头颈癌幸存者中,65,486例(25.4%)诊断有焦虑和/或抑郁障碍。
  • 倾向性评分匹配后,有焦虑和/或抑郁障碍者较无该障碍者死亡风险显著更高(HR 1.07,95%CI 1.05-1.09)。
  • 有焦虑障碍者较无焦虑障碍者死亡风险显著更高(HR 1.08,95%CI 1.05-1.10);有抑郁障碍者与无抑郁障碍者相比无显著差异(HR 1.01,95%CI 0.99-1.04)。
  • 诊断头颈癌和焦虑和/或抑郁障碍者中,39,923例(61.0%)接受药物治疗和/或心理治疗。
  • 接受药物治疗和/或心理治疗者(HR 0.94,95%CI 0.91-0.97)、药物治疗者(HR 0.94,95%CI 0.91-0.97)或心理治疗者(HR 0.75,95%CI 0.68-0.82)较未接受相应治疗者死亡风险更低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study seeks to evaluate the relationship between anxiety and/or depressive disorders and survival among head and neck cancer (HNC) survivors as well as the impact of treatment of mental health disorders on survival. METHODS: This is a retrospective cohort study utilizing deidentified electronic medical record data from TriNetX. Cohorts of adults were generated, including HNC survivors with and without a diagnosis of selected anxiety and/or depressive disorders. Among those with a selected anxiety and/or depressive disorder, cohorts were created for those with and without treatment of those disorders. Finally, Kaplan-Meier curves were utilized to compare the risk of mortality between groups after propensity score matching groups for relevant demographic and medical characteristics. RESULTS: Among 258,259 adult HNC survivors, 65,486 (25.4%) were diagnosed with an anxiety and/or depressive disorder. After propensity score matching between groups, adults with an anxiety and/or depressive disorder (HR: 1.07 [95% CI: 1.05-1.09]), an anxiety disorder (HR: 1.08 [95% CI: 1.05-1.10]), but not a depressive disorder (HR: 1.01 [95% CI: 0.99-1.04]) had a significantly higher risk of mortality than those without. Among those diagnosed with HNC and anxiety and/or depressive disorders, 39,923 (61.0%) received pharmacotherapy and/or psychotherapy. Those treated with pharmacotherapy and/or psychotherapy (HR: 0.94 [95% CI: 0.91-0.97]), pharmacotherapy (HR: 0.94 [95% CI: 0.91-0.97]), or psychotherapy (HR: 0.75 [95% CI: 0.68-0.82]) had a lower risk of mortality compared to those without. CONCLUSIONS: This retrospective cohort study suggests that a history of anxiety and/or depressive disorder is associated with worse survival among HNC survivors and that treatment of that anxiety and/or depressive disorder may ameliorate that increased risk of mortality.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Gallagher TJ, Lin ME, Kim I, et al. Reduced Mortality With Treatment of Anxiety and Depression Among Head and Neck Cancer Survivors. Laryngoscope. 2025. PMID: 40497673. doi:10.1002/lary.32340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。